Starlix Tablet
Nateglinide
120mg
Novartis Farma SpA, Italy
| Pack size | 84's pack |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 28.11 AED |
Indications
Starlix Tablet is used for:
Type 2 DM
Adult Dose
Oral
Type 2 diabetes mellitus
Adult: 60 or 120 mg tid.
Child Dose
Renal Dose
Administration
Take immediately before or up to ½ hr before meals.
Contra Indications
Diabetic ketoacidosis; IDDM. Lactation.
Precautions
Geriatric patients, debilitated and malnourished patients; adrenal or pituitary insufficiency, moderate to severe hepatic impairment; severe renal impairment. Monitor glycaemic levels during periods of stress. Pregnancy.
Lactation: unsafe
Pregnancy-Lactation
Pregnancy Category: C
Lactation: unsafe
Interactions
Increased levels/effects with enzyme inhibitors (e.g. fluconazole). Increased hypoglycaemic effects with salicylates, MAOIs, nonselective beta-blockers, alcohol, NSAIDs. Decreased levels/effects with enzyme inducers (e.g. rifampicin). Decreased hypoglycaemic effects with thiazide diuretics, corticosteroids, thyroid products and sympathomimetic agents.
Adverse Effects
Side effects of Nateglinide :
1-10%
Increased uric acid (10%),Dizziness (4%),Arthropathy (3%),Flu-like syndrome,Weight gain,Hypoglycemia (2%)
Frequency Not Defined
Diarrhea,Nausea
Mechanism of Action
Nateglinide, a nonsulfonylurea hypoglycaemic agent, acts by stimulating insulin release from pancreatic ?-cells to reduce postprandial hyperglycaemia. This action depends on the amount of existing glucose levels.
Note
Starlix 120mg Tablet manufactured by Novartis Farma SpA, Italy. Its generic name is Nateglinide. Starlix is availble in Bangladesh.
Farmaco BD drug index information on Starlix Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.